Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1209 | 1033 | 1285 | 1320 | 1731 | 3032 |
Fund Return | 20.87% | 3.32% | 28.54% | 9.69% | 11.6% | 11.73% |
Place in category | 441 | 494 | 796 | 170 | 250 | 46 |
% in Category | 27 | 31 | 49 | 14 | 22 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mackenzie Global Div Fund A CAD | 6.94B | 19.38 | 8.08 | 10.21 | ||
Mackenzie Global Div Fund PW CAD | 6.94B | 19.75 | 8.48 | 10.57 | ||
Mackenzie Global Div Fund PWX | 6.94B | 21.94 | 10.84 | 13.01 | ||
Mackenzie Global Div Fund PWTB | 6.94B | 19.78 | 8.50 | 10.60 | ||
Mackenzie Global Div Fund T5 CAD | 6.94B | 19.38 | 8.07 | 10.19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 14.78B | 43.16 | 12.27 | - | ||
Mawer Global Equity | 13.71B | 8.62 | 5.37 | 10.93 | ||
Capital Group Glbal Equity Fd F CAD | 13.66B | 22.86 | 3.88 | 11.66 | ||
Capital Group Glbal Equity Fd A CAD | 13.66B | 21.74 | 2.74 | 10.43 | ||
Capital Group Glbal Equity Fd D CAD | 13.66B | 22.55 | 3.53 | 11.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 4.41 | 413.81 | +0.23% | |
Apple | US0378331005 | 4.06 | 229.88 | +0.60% | |
JPMorgan | US46625H1005 | 2.86 | 248.12 | +1.37% | |
Amazon.com | US0231351067 | 2.51 | 197.69 | -0.35% | |
AbbVie | US00287Y1091 | 2.34 | 177.92 | +3.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review